Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.

Anticancer Drugs. 2014 Apr;25(4):368-74.

Vázquez S1, Lázaro M, Fírvida JL, Santomé L, Afonso J, Amenedo M, Casal J; Galician Lung Cancer Group (GGCP).

Vázquez S1 et al.
Ver